SPRO Market Cap History



Below is a table of the SPRO market cap history going back to 11/2/2017:

Date SPRO Market Cap
11/2/2017154.07M
11/30/2017171.71M
3/28/2018203.90M
5/7/2018177.85M
8/6/2018211.66M
11/5/2018154.78M
3/8/2019202.29M
5/6/2019200.65M
8/5/2019168.09M
8/6/2019166.47M
10/31/2019209.84M
3/9/2020172.79M
5/1/2020246.94M
7/30/2020258.06M
10/29/2020365.40M
3/8/2021478.26M
4/29/2021406.12M
7/29/2021441.05M
11/5/2021566.31M
3/25/2022266.96M
5/12/202255.80M
8/5/202228.05M
11/10/2022100.96M
3/1/202379.38M
5/1/202397.26M
8/4/202379.57M
11/6/202361.48M
3/8/202489.42M
5/6/202489.62M

Also see: SPRO Shares Outstanding History
and SPRO YTD Return
SPRO Historical Market Cap:
-7.98% CAGR
SPRO Historical Market Cap: +-7.98% CAGR

Mouse over chart for data details
11/2/2017 ...5/6/2024
Spero Therapeutics is a biopharmaceutical company focused on identifying, developing, and commercializing treatments involving bacterial infections. Co.'s product candidate, SPR720, is an oral antimicrobial agent in development for the treatment of nontuberculous mycobacterial pulmonary disease. Co.'s partnership-directed programs consist of tebipenem pivoxil hydrobromide, which is designed to be oral carbapenem-class antibiotic for use to treat certain bacterial infections that cause complicated urinary tract infections; and SPR206, which is an IV-administered antibiotic being developed as an option to treat multi-drug resistant Gram-negative bacterial infections in the hospital setting. We show 29 historical shares outstanding datapoints in our SPRO shares outstanding history coverage, used to compute SPRO market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SPRO market cap history over the course of time is important for investors interested in comparing SPRO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SPRO versus a peer is one thing; comparing SPRO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SPRO can fluctuate over the course of history. With this page we aim to empower investors researching SPRO by allowing them to research the SPRO market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree SPRO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Spero Therapeutics (SPRO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

SPRY Market Cap History
SQL Market Cap History
SQZ Market Cap History
SRDX Market Cap History
SRGA Market Cap History
SRNE Market Cap History
SRPT Market Cap History
SRRA Market Cap History
SRRK Market Cap History
SRTS Market Cap History
More Healthcare companies »

 

SPRO Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.